help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imrie, H.
Right arrow Articles by Pearce, S. H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imrie, H.
Right arrow Articles by Pearce, S. H. S.
Right arrowPubmed/NCBI databases
*Gene*OMIM
*UniSTS
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 2 626-630
Copyright © 2001 by The Endocrine Society


Original Studies

Evidence for a Graves’ Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population1

Helen Imrie, Bijayeswar Vaidya, Petros Perros, William F. Kelly, Anthony D. Toft, Eric T. Young, Pat Kendall-Taylor and Simon H. S. Pearce

Endocrine Group, Department of Medicine, University of Newcastle upon Tyne (H.I., B.V., P.K.-T., S.H.S.P.), Newcastle upon Tyne, United Kingdom NE2 4HH; Department of Medicine, Freeman Hospital (P.P.), Newcastle upon Tyne, United Kingdom NE7 7DN; Diabetes Care Center, Middlesbrough General Hospital (W.F.K.), Middlesbrough, United Kingdom TS5 5AZ; Endocrine Unit, Royal Infirmary of Edinburgh (A.D.T.), Edinburgh, United Kingdom EH3 9YW; and Department of Medicine, Wansbeck General Hospital (E.T.Y.), Ashington, Northumbria, United Kingdom NE63 9JJ

Address all correspondence and requests for reprints to: Dr. Simon Pearce, Department of Medicine, 4th Floor, Leech Building, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom NE2 4HH. E-mail: spearce{at}hgmp.mrc.ac.uk

Graves’ disease (GD), which has a strong female preponderance (female/male ratio, >5:1), is inherited as a complex genetic trait. Loci for GD have started to be defined using genome-wide approaches for genetic linkage. To date, 3 loci have been confirmed in at least 2 cohorts of GD patients, the strongest effect being at the cytotoxic T lymphocyte antigen-4 (CTLA-4) locus on chromosome 2q33 in our population. Two other loci for GD have recently been proposed, but not confirmed, on chromosomes Xq21 (GD3) and 14q31 (GD1). We studied a cohort of 75 sibling pairs with GD from the United Kingdom for linkage to 12 markers over a 83-cM region of the X chromosome and for 8 markers over a 36-cM region of 14q31-q33. A peak multipoint nonparametric linkage score of 2.21 (P = 0.014) was found at marker DXS8083 on Xp11, which increased to a nonparametric linkage score of 3.18 (P = 0.001) in data that had been conditioned for allele sharing at the CTLA-4 locus under an epistatic model. There was no evidence to support linkage of GD to Xq21.33-q22 (GD3) or at the 14q31-q33 (GD1) region in our population. A locus with a moderate contribution to GD susceptibility ({lambda}s = 1.4) is likely to exist in the Xp11 region, but we are unable to confirm that the GD1 or the GD3 regions contain major susceptibility loci in our United Kingdom GD population.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
X. YIN, R. LATIF, Y. TOMER, and T. F. DAVIES
Thyroid Epigenetics: X Chromosome Inactivation in Patients with Autoimmune Thyroid Disease
Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. L. Chen and J. T. Prchal
X-linked clonality testing: interpretation and limitations
Blood, September 1, 2007; 110(5): 1411 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B. Herrera, M. Cader, D. Dyment, J. Bell, G. DeLuca, C. Willer, M. Lincoln, S. Ramagopalan, M. Chao, S-M. Orton, et al.
Multiple sclerosis susceptibility and the X chromosome
Multiple Sclerosis, August 1, 2007; 13(7): 856 - 864.
[Abstract] [PDF]


Home page
J Mol EndocrinolHome page
C. J Owen, J. A Eden, C. E Jennings, V. Wilson, T. D Cheetham, and S. H S Pearce
Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population.
J. Mol. Endocrinol., August 1, 2006; 37(1): 97 - 104.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. A. Aliesky, P. N. Pichurin, C.-R. Chen, R. W. Williams, B. Rapoport, and S. M. McLachlan
Probing the Genetic Basis for Thyrotropin Receptor Antibodies and Hyperthyroidism in Immunized CXB Recombinant Inbred Mice
Endocrinology, June 1, 2006; 147(6): 2789 - 2800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Invernizzi, M. Miozzo, C. Selmi, L. Persani, P. M. Battezzati, M. Zuin, S. Lucchi, P. L. Meroni, B. Marasini, S. Zeni, et al.
X Chromosome Monosomy: A Common Mechanism for Autoimmune Diseases
J. Immunol., July 1, 2005; 175(1): 575 - 578.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
Y.-C. Weng, M.-J. Wu, and W.-S. Lin
CT60 Single Nucleotide Polymorphism of the CTLA-4 Gene Is Associated with Susceptibility to Graves' Disease in the Taiwanese Population
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 259 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Bayer, S. Neumann, B. Meyer, F. Ruschendorf, A. Reske, T. Brix, L. Hegedus, P. Langer, P. Nurnberg, and R. Paschke
Genome-Wide Linkage Analysis Reveals Evidence for Four New Susceptibility Loci for Familial Euthyroid Goiter
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4044 - 4052.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. Owen, C. E. Jennings, H. Imrie, A. Lachaux, N. A. Bridges, T. D. Cheetham, and S. H. S. Pearce
Mutational Analysis of the FOXP3 Gene and Evidence for Genetic Heterogeneity in the Immunodysregulation, Polyendocrinopathy, Enteropathy Syndrome
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6034 - 6039.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Y. Tomer and T. F. Davies
Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function
Endocr. Rev., October 1, 2003; 24(5): 694 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Collins, J. M. Heward, J. Carr-Smith, J. Daykin, J. A. Franklyn, and S. C. L. Gough
Association of a Rare Thyroglobulin Gene Microsatellite Variant with Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5039 - 5042.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. H. Kacem, A. Rebai, N. Kaffel, S. Masmoudi, M. Abid, and H. Ayadi
PDS Is a New Susceptibility Gene to Autoimmune Thyroid Diseases: Association and Linkage Study
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2274 - 2280.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce
The Genetics of Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Segni, M. A. Pani, A. M. Pasquino, and K. Badenhoop
Familial Clustering of Juvenile Thyroid Autoimmunity: Higher Risk Is Conferred by Human Leukocyte Antigen DR3-DQ2 and Thyroid Peroxidase Antibody Status in Fathers
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3779 - 3782.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Pani, K. Regulla, M. Segni, S. Hofmann, M. Hufner, A. M. Pasquino, K.-H. Usadel, and K. Badenhoop
A Polymorphism within the Vitamin D-Binding Protein Gene Is Associated with Graves' Disease but Not with Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2564 - 2567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society